Tachycardia-induced heart failure does not alter myocardial P-glycoprotein expression.
To determine the effects of tachycardia-induced heart failure on myocardial P-glycoprotein (P-gp) expression. Nonblinded, parallel, sham-controlled, animal model study. University laboratory. Thirty mongrel dogs. Heart failure was induced by rapid ventricular pacing over 4 weeks; sham procedures were performed for the control group. Myocardial biopsies were taken from the left ventricular lateral wall and prepared for P-gp quantification by laser-induced fluorescence. The relative amount of P-gp messenger RNA (mRNA) was assessed by reverse transcriptase polymerase chain reaction. Rapid ventricular pacing produced heart failure and reduced the area ejection fraction from 48% +/- 6% to 21% +/- 6% (p<0.05 vs baseline). However, heart failure did not alter the quantity of myocardial P-gp (0.20 +/- 0.02 microg/ml for the control group vs 0.23 +/- 0.02 microg/ml for the intervention group, p=0.4). Furthermore, heart failure did not alter P-gp expression significantly. Myocardial P-gp does not change in response to tachycardia-induced heart failure. Thus, there is a low likelihood for P-gp-related drug resistance during a syndrome similar to tachycardia-induced heart failure.